From research to therapy, Horizon Discovery, a PerkinElmer company, drives the application of gene editing and gene modulation. Innovative tools and services enable scientists to gain a greater understanding of the genetic drivers behind disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine.
Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from discovery research to clinical trials to commercial applications. These products are critical raw materials and key components in commercially available drugs and medical devices.
Aldevron is known for inventing the GMP-Source® quality system and for specializing in cGMP manufacturing, operating the world’s largest facility at its company headquarters in Fargo, North Dakota, with additional facilities in Madison, Wisconsin.
Mission Bio helps you accelerate research and therapeutic development for a variety of genetic diseases. Powered single-cell multi-omics, our Tapestri Platform helps unravel the complexity of cancer through high-resolution tumor profiling and disease modeling. Discover how we enable cell and gene therapy development through the accurate characterization of therapeutic candidates. We partner with pharma and biopharma companies across advanced therapy development programs to implement proven single-cell multi-omics capabilities into discovery, translational, and clinical research efforts.